Hormone replacement therapy (HRT) is given to relieve the climacteric symptoms of
menopause. Use of HRT reduced after a report from the Women's Health Initiative linked it to …

OBJECTIVE: To assess whether recent epidemiologic evidence supports an association
between use of estrogen replacement therapy or hormone replacement therapy and risk of …

Background: We previously showed that women with abnormal cytology in breast fluid
obtained by nipple aspiration had an increased relative risk (RR) of breast cancer compared …

Women with benign breast diseases (BBD), particularly those with lesions classified as
proliferative, have previously been reported to be at increased risk for subsequent …

We conducted meta-analyses to assess the impact of menopausal hormone therapy (MHT)
on the risk of incident invasive breast cancer (BC) in cohort studies (CS), case–control …

Background The majority of studies have reported risks of breast cancer (BC) from benign
breast disease (BBD) in essentially homogenous Caucasian populations. Information on …

BACKGROUND. Mammary columnar cell lesions with atypia have been receiving increased
scrutiny in view of their association with atypical hyperplasia (AH) and carcinoma. However …

This book provides a practical, unbiased and non-promotional international guide for all
health professionals dealing with menopausal and postmenopausal women. With regard to …

Breast health means more than breast cancer. The majority of patients seen over the years
at the author's Multidisciplinary Breast Health Center have benign conditions. It has been …

OBJECTIVE: Substitution of estrogens (hormone replacement therapy [HRT]) is the most
common therapy and prophylaxis of postmenopausal complaints. However, in most studies …